Related Experiment Video
Updated: Aug 28, 2026

Primed Mycobacterial Uveitis (PMU) as a Model for Post-Infectious Uveitis
Published on: December 17, 2021
IVIG-associated anterior uveitis resolving after switch to subcutaneous immunoglobulin
Vered Schichter Konfino1,2, Oded Shamriz3,4
1Allergy and Clinical Immunology Unit, Hillel Yaffe Medical Center, Hadera, Israel.
Introduction:
Intravenous immunoglobulin (IVIG) therapy can occasionally induce unexpected inflammatory complications.
Materials And Methods:
A case report and literature review.
Results:
We report a patient with hypogammaglobulinemia and systemic autoimmunity who developed reproducible unilateral anterior uveitis following IVIG administration across multiple formulations. Discontinuation of IVIG resolved the ocular inflammation but caused underlying disease exacerbation. Transition to facilitated subcutaneous immunoglobulin (SCIG) achieved stable serum IgG levels and maintained complete ocular and systemic remission over a four-year follow-up period.
Conclusion:
This case demonstrates peak-driven immune activation as a plausible mechanism for IVIG-induced uveitis and highlights SCIG as a safe, effective therapeutic alternative that bypasses rapid peak IgG dynamics while preserving immune protection.
Related Concept Videos
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
Angle Closure Glaucoma: Treatment
Autoimmune Disorders
Concept and Mechanism of Autoimmune Diseases
The immune system...
Transcytosis of IgG
IgG molecules from a mother undergo transcytosis starting around 13 weeks of gestation. The amount of IgG transferred and entering the fetal blood circulation increases with...
Hypersensitivity Reactions: Immune-Complex Reactions
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
